Ikarian Capital, LLC
- SEC CIK
- 0001778253
- 最新申報
- 2026/8/14
2022 年第 1 季持倉
持倉截至 2022/3/31，2022/5/13 申報。只含多頭部位，變化是跟 2021 年第 4 季比股數。
- 持股檔數
- 155
- 較 2021 年第 4 季 +6
- 總值
- $3.29 億
- 較 2021 年第 4 季 −$2,074 萬 (−5.9%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 478,784 | $2,101 萬 | 6.4% | −134,342−21.9% | 減碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 537,958 | $1,832 萬 | 5.6% | +118,742+28.3% | 加碼 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 1,083,116 | $1,800 萬 | 5.5% | +62,199+6.1% | 加碼 | 歷史 |
| MISTMilestone Pharmaceuticals Inc. | COM | 1,928,752 | $1,238 萬 | 3.8% | +178,709+10.2% | 加碼 | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 110,116 | $1,159 萬 | 3.5% | +34,455+45.5% | 加碼 | 歷史 |
| ACETAdicet Bio, Inc. | COM | 507,348 | $1,013 萬 | 3.1% | +29,930+6.3% | 加碼 | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 202,203 | $932.9 萬 | 2.8% | +11,063+5.8% | 加碼 | 歷史 |
| SAGESage Therapeutics, Inc. | COM | 249,907 | $827.2 萬 | 2.5% | +249,907 | 新進 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 315,991 | $763.0 萬 | 2.3% | +20,880+7.1% | 加碼 | 歷史 |
| TCONTracon Pharmaceuticals, Inc. | COM NEW | 2,843,232 | $747.7 萬 | 2.3% | +152,122+5.7% | 加碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 239,441 | $732.0 萬 | 2.2% | +60,303+33.7% | 加碼 | 歷史 |
| BHVNBiohaven Ltd. | COM | 60,000 | $711.4 萬 | 2.2% | +60,000 | 新進 | 歷史 |
| SRRASierra Oncology, Inc. | COM NEW | 217,915 | $698.3 萬 | 2.1% | −351,114−61.7% | 減碼 | 歷史 |
| GOSSGossamer Bio, Inc. | COM | 775,315 | $673.0 萬 | 2.0% | −391,618−33.6% | 減碼 | 歷史 |
| VRTXVertex Pharmaceuticals Inc | Stock | 25,000 | $652.4 萬 | 2.0% | +25,000 | 新進 | 歷史 |
| RIGLRigel Pharmaceuticals Inc | COM NEW | 2,137,128 | $639.0 萬 | 1.9% | +1,697,772+386.4% | 加碼 | 歷史 |
| KRTXKaruna Therapeutics, Inc. | COM | 50,000 | $634.0 萬 | 1.9% | +50,000 | 新進 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 913,327 | $628.3 萬 | 1.9% | +863,327+1,726.7% | 加碼 | – |
| IMTXImmatics N.V. | SHS | 781,388 | $624.3 萬 | 1.9% | +43,842+5.9% | 加碼 | 歷史 |
| MCRBSeres Therapeutics, Inc. | COM | 840,624 | $598.6 萬 | 1.8% | +44,721+5.6% | 加碼 | 歷史 |
| SCPHscPharmaceuticals Inc. | COM | 970,098 | $551.0 萬 | 1.7% | +68,736+7.6% | 加碼 | 歷史 |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 86,865 | $541.3 萬 | 1.6% | 00.0% | 不變 | 歷史 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 396,654 | $509.7 萬 | 1.6% | +396,654 | 新進 | 歷史 |
| AMGNAmgen Inc | Stock | 20,000 | $483.7 萬 | 1.5% | +20,000 | 新進 | 歷史 |
| PFEPfizer Inc | Stock | 80,000 | $414.2 萬 | 1.3% | +80,000 | 新進 | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 50,000 | $385.6 萬 | 1.2% | +50,000 | 新進 | 歷史 |
| CMRXChimerix Inc | COM | 841,203 | $385.2 萬 | 1.2% | +45,793+5.8% | 加碼 | 歷史 |
| WHWKWhitehawk Therapeutics, Inc. | COM | 208,368 | $353.6 萬 | 1.1% | +11,960+6.1% | 加碼 | 歷史 |
| INBXInhibrx Biosciences, Inc. | COM | 157,842 | $351.6 萬 | 1.1% | +7,992+5.3% | 加碼 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 47,408 | $344.5 萬 | 1.0% | +47,408 | 新進 | 歷史 |
| RETAReata Pharmaceuticals Inc | CL A | 86,905 | $284.6 萬 | 0.9% | +86,905 | 新進 | 歷史 |
| AYLAOld Ayala, Inc | COM | 708,383 | $281.9 萬 | 0.9% | +39,112+5.8% | 加碼 | 歷史 |
| STSASatsuma Pharmaceuticals, Inc. | COM | 653,448 | $248.2 萬 | 0.8% | +24,064+3.8% | 加碼 | 歷史 |
| XFORX4 Pharmaceuticals, Inc | COM | 1,372,022 | $240.2 萬 | 0.7% | −892,469−39.4% | 減碼 | 歷史 |
| PRDSPardes Biosciences, Inc. | COM | 323,934 | $233.8 萬 | 0.7% | −76,066−19.0% | 減碼 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 738,372 | $231.9 萬 | 0.7% | +33,290+4.7% | 加碼 | 歷史 |
| SVRASavara Inc | COM | 1,622,552 | $212.6 萬 | 0.6% | +82,861+5.4% | 加碼 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 50,000 | $211.7 萬 | 0.6% | +50,000 | 新進 | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 1,048,039 | $209.5 萬 | 0.6% | +54,558+5.5% | 加碼 | 歷史 |
| CABACabaletta Bio, Inc. | COM | 1,020,070 | $207.0 萬 | 0.6% | +49,672+5.1% | 加碼 | 歷史 |
| CNTBConnect Biopharma Holdings Ltd | ADS | 677,859 | $204.7 萬 | 0.6% | +415,622+158.5% | 加碼 | 歷史 |
| CLNNClene Inc. | COMMON STOCK | 514,283 | $202.6 萬 | 0.6% | +24,962+5.1% | 加碼 | 歷史 |
| LQDALiquidia Corp | COM NEW | 243,904 | $175.1 萬 | 0.5% | −81,541−25.1% | 減碼 | 歷史 |
| GBTGlobal Blood Therapeutics, Inc. | COM | 49,997 | $173.2 萬 | 0.5% | −114,085−69.5% | 減碼 | 歷史 |
| LYRALyra Therapeutics, Inc. | COM | 422,338 | $169.8 萬 | 0.5% | +27,802+7.0% | 加碼 | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 375,000 | $166.7 萬 | 0.5% | +375,000 | 新進 | 歷史 |
| FNCHFinch Therapeutics Group, Inc. | COM | 330,523 | $166.2 萬 | 0.5% | +14,791+4.7% | 加碼 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 532,429 | $159.6 萬 | 0.5% | +31,787+6.3% | 加碼 | 歷史 |
| CLVSClovis Oncology, Inc. | COM | 772,339 | $156.1 萬 | 0.5% | −340,330−30.6% | 減碼 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 372,217 | $155.2 萬 | 0.5% | −172,602−31.7% | 減碼 | 歷史 |
| TARAProtara Therapeutics, Inc. | COM STK | 296,426 | $151.5 萬 | 0.5% | +17,170+6.1% | 加碼 | 歷史 |
| RNTXRein Therapeutics, Inc. | COM | 2,902,086 | $148.7 萬 | 0.5% | +138,503+5.0% | 加碼 | 歷史 |
| RCORRenovacor, Inc. | COM | 343,283 | $145.6 萬 | 0.4% | +381+0.1% | 加碼 | 歷史 |
| MGNXMacrogenics Inc | COM | 164,119 | $144.6 萬 | 0.4% | +8,072+5.2% | 加碼 | 歷史 |
| ELDNEledon Pharmaceuticals, Inc. | COM | 362,537 | $142.9 萬 | 0.4% | +17,959+5.2% | 加碼 | 歷史 |
| MRUSMerus N.V. | COM | 53,703 | $142.0 萬 | 0.4% | +2,796+5.5% | 加碼 | 歷史 |
| NTBLNotable Labs, Ltd. | COM | 830,747 | $140.4 萬 | 0.4% | +39,909+5.0% | 加碼 | 歷史 |
| CMMBChemomab Therapeutics Ltd. | SPONSORED ADS | 268,104 | $129.2 萬 | 0.4% | +2,840+1.1% | 加碼 | 歷史 |
| SYBXSynlogic, Inc. | COM | 519,775 | $124.8 萬 | 0.4% | +35,957+7.4% | 加碼 | 歷史 |
| ANEBAnebulo Pharmaceuticals, Inc. | COM | 181,199 | $122.5 萬 | 0.4% | +8,890+5.2% | 加碼 | 歷史 |
| TAOXTAO Synergies Inc. | COM NEW | 153,226 | $118.6 萬 | 0.4% | +7,597+5.2% | 加碼 | 歷史 |
| Bellicum Pharmaceuticals, Inc079481404 | COM NEW | 523,348 | $113.1 萬 | 0.3% | +26,592+5.4% | 加碼 | – |
| NUVBNuvation Bio Inc. | COM CL A | 213,310 | $112.2 萬 | 0.3% | +13,310+6.7% | 加碼 | 歷史 |
| AUPHAurinia Pharmaceuticals Inc. | COM | 87,071 | $107.7 萬 | 0.3% | +4,736+5.8% | 加碼 | 歷史 |
| PHATPhathom Pharmaceuticals, Inc. | COM | 78,550 | $106.9 萬 | 0.3% | +3,990+5.4% | 加碼 | 歷史 |
| CASICASI Pharmaceuticals, Inc (DE) | COM | 1,320,155 | $106.7 萬 | 0.3% | +97,088+7.9% | 加碼 | 歷史 |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 316,939 | $104.7 萬 | 0.3% | +6,829+2.2% | 加碼 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 8,763 | $102.8 萬 | 0.3% | +363+4.3% | 加碼 | 歷史 |
| BCLIBrainstorm Cell Therapeutics Inc. | COM NEW | 304,161 | $102.2 萬 | 0.3% | +14,611+5.0% | 加碼 | 歷史 |
| MXCTMaxcyte, Inc. | COM | 137,958 | $96.4 萬 | 0.3% | +7,958+6.1% | 加碼 | 歷史 |
| VSTMVerastem, Inc. | COM | 678,023 | $95.6 萬 | 0.3% | +40,652+6.4% | 加碼 | 歷史 |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 510,126 | $83.7 萬 | 0.3% | +27,516+5.7% | 加碼 | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 49,099 | $82.5 萬 | 0.3% | +2,580+5.5% | 加碼 | 歷史 |
| BCLS Acquisition CorpG0904B105 | COM CL A | 77,274 | $76.2 萬 | 0.2% | +3,485+4.7% | 加碼 | – |
| HEPAHepion Pharmaceuticals, Inc. | COM | 582,137 | $75.1 萬 | 0.2% | +28,864+5.2% | 加碼 | 歷史 |
| PBLAPanbela Therapeutics, Inc. | COM | 355,959 | $75.0 萬 | 0.2% | +17,577+5.2% | 加碼 | 歷史 |
| QSIQuantum-Si Inc | COM CL A | 157,363 | $73.6 萬 | 0.2% | +12,957+9.0% | 加碼 | 歷史 |
| NXTCNextCure, Inc. | COM | 141,058 | $68.6 萬 | 0.2% | +7,003+5.2% | 加碼 | 歷史 |
| IFRXInflaRx N.V. | COM | 349,468 | $63.9 萬 | 0.2% | +18,420+5.6% | 加碼 | 歷史 |
| PLRXPliant Therapeutics, Inc. | COM | 90,805 | $63.6 萬 | 0.2% | +4,093+4.7% | 加碼 | 歷史 |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 511,186 | $63.3 萬 | 0.2% | +35,493+7.5% | 加碼 | 歷史 |
| SLDBSolid Biosciences Inc. | COM | 521,155 | $62.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 92,223 | $61.9 萬 | 0.2% | +4,643+5.3% | 加碼 | 歷史 |
| IRONDisc Medicine, Inc. | COM | 443,096 | $61.5 萬 | 0.2% | +22,046+5.2% | 加碼 | 歷史 |
| QCLSQ/C Technologies, Inc. | COM | 131,389 | $61.2 萬 | 0.2% | +7,389+6.0% | 加碼 | 歷史 |
| TENXTenax Therapeutics, Inc. | COM NEW | 735,097 | $59.6 萬 | 0.2% | +40,902+5.9% | 加碼 | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 21,801 | $58.8 萬 | 0.2% | +1,058+5.1% | 加碼 | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 39,730 | $58.6 萬 | 0.2% | +3,154+8.6% | 加碼 | 歷史 |
| KRSAKorsana Biosciences, Inc. | COM | 527,462 | $58.5 萬 | 0.2% | +24,835+4.9% | 加碼 | 歷史 |
| HARPHarpoon Therapeutics, Inc. | COM | 117,009 | $58.2 萬 | 0.2% | +5,717+5.1% | 加碼 | 歷史 |
| ICPTIntercept Pharmaceuticals, Inc. | COM | 35,149 | $57.2 萬 | 0.2% | +584+1.7% | 加碼 | 歷史 |
| AVTXAvalo Therapeutics, Inc. | COM | 764,271 | $55.4 萬 | 0.2% | +45,566+6.3% | 加碼 | 歷史 |
| DMACDiaMedica Therapeutics Inc. | COM NEW | 221,252 | $55.3 萬 | 0.2% | +12,170+5.8% | 加碼 | 歷史 |
| MBIOMustang Bio, Inc. | COM | 546,824 | $55.1 萬 | 0.2% | +40,791+8.1% | 加碼 | 歷史 |
| OKUROnKure Therapeutics, Inc. | COM | 185,597 | $54.6 萬 | 0.2% | +10,597+6.1% | 加碼 | 歷史 |
| VTVTvTv Therapeutics Inc. | CL A | 742,980 | $53.6 萬 | 0.2% | +42,980+6.1% | 加碼 | 歷史 |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM | 997,627 | $53.0 萬 | 0.2% | +49,101+5.2% | 加碼 | 歷史 |
| KODKodiak Sciences Inc. | COM | 68,100 | $52.6 萬 | 0.2% | +68,100 | 新進 | 歷史 |
| OTICOtonomy, Inc. | COM | 218,538 | $52.5 萬 | 0.2% | +10,232+4.9% | 加碼 | 歷史 |
| ASMBAssembly Biosciences, Inc. | COM | 227,076 | $46.8 萬 | 0.1% | +12,215+5.7% | 加碼 | 歷史 |
選擇權（31 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | – | $8,409 萬 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | $1,924 萬 | $2,208 萬 |
| NBIXNeurocrine Biosciences Inc | Stock | – | $4,028 萬 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | $2,028 萬 | $1,172 萬 |
| BMRNBiomarin Pharmaceutical Inc | COM | – | $2,419 萬 |
| AMGNAmgen Inc | Stock | – | $2,418 萬 |
| BIIBBiogen Inc. | COM | – | $2,363 萬 |
| RETAReata Pharmaceuticals Inc | CL A | $2,128 萬 | $50.2 萬 |
| GILDGilead Sciences, Inc. | Stock | $1,078 萬 | $1,078 萬 |
| UTHRUnited Therapeutics Corp | COM | – | $1,794 萬 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | – | $1,663 萬 |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | $467.7 萬 | $1,162 萬 |
| LONALeonaBio, Inc. | COM | $270.0 萬 | $1,059 萬 |
| APLSApellis Pharmaceuticals, Inc. | COM | – | $889.6 萬 |
| SAGESage Therapeutics, Inc. | COM | – | $827.5 萬 |
| RCUSArcus Biosciences, Inc. | COM | – | $473.4 萬 |
| KZRKezar Life Sciences, Inc. | COM | – | $466.6 萬 |
| PMVPPMV Pharmaceuticals, Inc. | COM | $208.2 萬 | $208.2 萬 |
| BPMCBlueprint Medicines Corp | COM | – | $408.8 萬 |
| PTGXProtagonist Therapeutics, Inc | COM | – | $380.6 萬 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | – | $321.3 萬 |
| ZLABZai Lab Ltd | ADR | – | $233.6 萬 |
| GOSSGossamer Bio, Inc. | COM | $12.9 萬 | $183.6 萬 |
| INBXInhibrx Biosciences, Inc. | COM | – | $191.1 萬 |
| AKBAAkebia Therapeutics, Inc. | COM | $86.0 萬 | $57.5 萬 |
| ACETAdicet Bio, Inc. | COM | – | $124.1 萬 |
| CABACabaletta Bio, Inc. | COM | – | $91.2 萬 |
| KODKodiak Sciences Inc. | COM | $56.5 萬 | $19.9 萬 |
| TCDATricida, Inc. | COM | $76.4 萬 | – |
| NKTRNektar Therapeutics | COM | – | $72.2 萬 |
| IMUXImmunic, Inc. | COM | $69.6 萬 | – |
2021 年第 4 季之後清倉（10 檔）
2021 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 4 季股數 | 2021 年第 4 季市值 | 2021 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| iShares Tr464287556 | ISHARES BIOTECH | 24,022 | $366.6 萬 | 1.0% | – |
| IOVAIovance Biotherapeutics, Inc. | COM | 172,521 | $329.4 萬 | 0.9% | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 23,700 | $200.8 萬 | 0.6% | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 164,174 | $189.6 萬 | 0.5% | 歷史 |
| ODTOdonate Therapeutics, Inc. | COM | 1,340,631 | $181.0 萬 | 0.5% | 歷史 |
| RFLRafael Holdings, Inc. | COM CL B | 72,515 | $37.0 萬 | 0.1% | 歷史 |
| ARNAArena Pharmaceuticals Inc | COM NEW | 2,161 | $20.0 萬 | 0.1% | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 1,500 | $2.50 萬 | <0.1% | 歷史 |
| BXRXBaudax Bio, Inc. | COM | 95,059 | $2.10 萬 | <0.1% | 歷史 |
| Frazier Lifesciences Acqu CoG3710A121 | UNIT 12/09/2025 | 941 | $9,000 | <0.1% | – |